NEOADJUVANT, ADJUVANT AND 1ST LINE

Clinical trials for NEOADJUVANT, ADJUVANT AND 1ST LINE explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT, ADJUVANT AND 1ST LINE trials appear

Sign up with your email to follow new studies for NEOADJUVANT, ADJUVANT AND 1ST LINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major cancer registry launches to map treatment paths for rare bile duct cancers

Knowledge-focused Completed

This study created a permanent registry to collect information from people with bile duct cancer in Germany. It tracked what treatments patients received, how they felt, and how the disease progressed, but did not test any new treatments. The goal was to gather real-world data to…

Matched conditions: NEOADJUVANT, ADJUVANT AND 1ST LINE

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused

Last updated Mar 16, 2026 15:24 UTC

NEOADJUVANT, ADJUVANT AND 1ST LINE

Get alerted when new NEOADJUVANT, ADJUVANT AND 1ST LINE trials appear

Major cancer registry launches to map treatment paths for rare bile duct cancers